GlassScriptPhysician profile
David A Cocanower
NPI 1235270745
$1,541.67
in general payments reported to CMS, 2019-2025
16 companies · $27.65 in 2025
The $27.65 reported for 2025 was less than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $637 · 2020: $384 · 2021: $174 · 2022: $90.54 · 2023: $108 · 2024: $121 · 2025: $27.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $211 · Education: $45.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $211.31 |
| Education | $45.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $540.00 | 2019 | |
| Jazz Pharmaceuticals INC. | $406.89 | 2019-2024 | |
| Harmony Biosciences LLC | $250.35 | 2020-2023 | Wakix |
| Somnomed INC. | $65.98 | 2022 | |
| Novo Nordisk INC | $43.92 | 2019-2021 | |
| Philips North America LLC | $33.51 | 2023-2024 | (7999) Src Undivided |
| Boston Scientific Corporation | $27.65 | 2025 | Watchman Flx |
| Genzyme Corporation | $27.63 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.56 | 2022 | |
| Gilead Sciences, INC. | $20.76 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $18.91 | 2023 | |
| Eisai INC. | $18.65 | 2024 | |
| Axsome Therapeutics, INC. | $16.18 | 2024 | Sunosi |
| Janssen Pharmaceuticals, INC | $16.01 | 2021 | |
| Grifols USA, LLC | $15.87 | 2024 | Prolastin-C Liquid |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cocanower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.